Share on Pinterest A newly approved drug for the treatment of atopic dermatitis could make a big ... Among the common side effects of EBGLYSS were eye and eyelid inflammation, including redness ...

If you or a loved one has just been diagnosed with atopic dermatitis (eczema), you may be learning about what triggers to avoid so you don’t experience a flare-up. Certain things can trigger ...

Allergies to the rubber processing chemicals are very common among health care workers and atopic patients ... with a characteristic dermatitis around their eyes, ears, and adjoining face ...

Supplemental allergy patch testing in patients with suspected ACD revealed allergens not detected in standard screening.

Often thought of as simple redness of the skin, eczema is a chronic inflammatory skin condition that most often results in ...

People with moderate to severe atopic dermatitis (a type of eczema ... or if you have been around someone who has had a serious infection such as tuberculosis (TB). You should also let them ...

Goblin is a special girl. Even though she pretty much walks around all the time in her birthday suit. The puppy is currently ...

EBGLYSS provides a new first-line biologic treatment for moderate-to-severe atopic dermatitis that is not well controlled with topicals Patients treated with EBGLYSS experienced significant skin ...

HORIZON Phase 3 trial evaluated rocatinlimab for atopic dermatitis (eczema) in 726 patients. Amgen reported that rocatinlimab outperformed a placebo regarding the severity and extent of the disease.

(RTTNews) - Arcutis Biotherapeutics Inc.'s (ARQT) ZORYVE cream 0.15% provided consistent and meaningful improvements in signs and symptoms of atopic dermatitis in individuals regardless of race ...

VTAMA cream is a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an additional ...

Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) ...